Follow The Filings

WST West Pharmaceutical Services Inc.

Health Care, filed as WEST PHARMACEUTICAL SVSC INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 8 managers in 2026 Q2

  • 3 Owners
  • Max 1.9%
  • $221M
  • 2 reduce 1 exit

In 2026 Q2 Hillman Capital Management and Ron Baron trimmed West Pharmaceutical Services, and Andreas Halvorsen sold out.

Who owns this now

Largest portfolio weights among holders, up to 1.9% (Hillman Capital Management). Not free-float ownership.

  1. Hillman Capital Management Reduce 1.9%
  2. Gates Foundation Trust 0.46%
  3. Ron Baron Reduce 0.09%

Who owns WST

Sorted by value, long equity only, as of 2026 Q2.

History
Gates Foundation Trust 0.46% Hold 444,500 $160M History
Ron Baron, Bamco Inc. (Baron Capital) 0.09%, was 0.15% Reduce −17.8% 164,174 $59M History
Hillman Capital Management 1.9% Reduce −20.2% 7,106 $2.6M History
Andreas Halvorsen, Viking Global Investors exited 2026 Q2 Last 2026 Q1 0.29% Exit −0.29% 416,948 $105M History

3 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by WST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WST insider trades
  • None no insider bought on the open market
  • $3.9M sold by 2 insiders outside a trading plan
  • $2.7M sold by 1 insider under 10b5-1 plans
  1. Annette F Favorite Sr. VP & Chief HR Officer
    Planned sale
    $2.7M 7,524 shares at $355.03 26% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  2. Annette F Favorite Sr. VP & Chief HR Officer
    Sale
    $2.8M 8,135 shares at $340.81 33% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  3. Annette F Favorite Sr. VP & Chief HR Officer
    Sale
    $860K 2,817 shares at $305.20 14% of stake
    Traded Apr 27 Filed Apr 29
    ↗
  4. Chad Winters VP, Chief Accounting Officer
    Sale
    $269K 896 shares at $300.67 37% of stake
    Traded Apr 27 Filed Apr 29
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 option exercises, 15 share withholdings for taxes, and 14 stock grants.

Congress

3 members of Congress traded WST in the last three years: 4 buys and 4 sales.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 22, 2025 filed Aug 13, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Apr 8, 2025 filed May 8, 2025
  4. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Feb 25, 2025 filed Mar 27, 2025
  5. Jared Moskowitz D-FL-23Child Sell $1K–$15K Feb 13, 2025 filed Mar 6, 2025
  6. Jared Moskowitz D-FL-23 Sell $1K–$15K Nov 8, 2024 filed Dec 9, 2024

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 1.05,9.01 Filing Doc
8-K 1.05,7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 21 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.95B $2.89B $3.07B
Gross profit $1.13B $0.998B $1.1B
Gross margin * 38.3% 34.5% 35.9%
Net income $593.4M $492.7M $493.7M
Net margin * 20.1% 17.0% 16.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.94B $1.54B $1.98B
Total non-current assets * $1.89B $2.11B $2.29B
Total assets $3.83B $3.64B $4.27B
Total current liabilities $671.8M $550.4M $654.9M
Total non-current liabilities * $276.7M $410.7M $439.1M
Total equity $2.88B $2.68B $3.18B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $776.5M $653.4M $754.8M
Cash from investing -$368.7M -$378.7M -$285.9M
Cash from financing -$459.6M -$622.6M -$185.1M
Net change in cash -$40.4M -$369.3M $306.7M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.